Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-055586

CEO and Chairman sold 43,499 shares at an average $38.43 ($1,671,496)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-08 Sale : show line 1 in the form −11,742 $38.34 $450,188 1,705,218 D
2021-09-08 Sale : show line 2 in the form −2,004 $39.11 $78,376 1,703,214 D
2021-09-09 Sale : show line 3 in the form −24,753 $38.42 $951,010 1,678,461 D
2021-09-10 Sale : show line 4 in the form −4,902 $38.37 $188,090 1,673,559 D
2021-09-10 Sale : show line 5 in the form −98 $39.09 $3,831 1,673,461 D
Open-market sales · 43,499 sh · avg $38.43 · $1,671,496
Loading xslF345X03/doc4.xml…